Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
glimepiride (amaryl) (1 trial)
sitagliptin (januvia) (1 trial)
ts-071 (1 trial)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Trials (2 total)
Trial APIs (3 total)